 Factors results direct ablative operations drug-refractory ventricular tachycardia Analysis patients period patients drug-resistant sustained ventricular tachycardia underwent direct surgical ablation arrhythmogenic myocardium Sixty-nine male female standard deviation ventricular tachycardia morphologies patient mean number drugs patient preoperative ventricular ejection fraction Complete preoperative endocardial mapping data endocardial sites ventricular tachycardia available patients intraoperative endocardial data clinical ventricular tachycardia patients patients computer-assisted techniques complete epicardial endocardial data clinical ventricular tachycardia patients Overall mapping data available Hospital mortality patients mean interval days days clinical ventricular tachycardia patients Nonclinical ventricular tachycardia patients patients postoperative ventricular tachycardia drugs major factors hospital mortality cardiopulmonary bypass minutes preoperative ejection fraction incomplete preoperative mapping Hospital mortality patients ejection fraction history amiodarone usage years follow-up freedom sudden cardiac death patients free ventricular tachycardia antiarrhythmic drugs results direct ventricular tachycardia operations effective form therapy patients sustained monomorphic ventricular tachycardia